Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples